PATENT CLAIM ANALYSIS

Application Number: 16131003
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["530", "350000"]

Abstract:
The invention herein disclosed is related to epitopes useful in methods of diagnosing, treating, and preventing coeliac disease. Therapeutic compositions which comprise at least one epitope are provided.

Claim (Index 1):
A method of preventing or treating coeliac disease comprising administering to an individual at least one agent selected from:\n (a) a peptide comprising at least one epitope comprising a sequence selected from the group consisting of SEQ ID NOs: 1-1927, and equivalents thereof; and (b) an analogue of (a) which is capable of being recognised by a T cell receptor that recognises the peptide of (a) and which is not more than 50 amino acids in length.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.06667
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14630004', '13541864', '10516837', '10089700', '11630818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6772561699487274
- 35 USC 102 Novelty (BERT): 0.5669088881563759
- Combined Prediction Score: 0.6662214417694923
- Mean Citation Score: 413.16597999999993
- Max Citation Score: 487.38614
- Similarity Product: 335.0045316422653

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test